title: Proceedings of the Fourth International Conference on Recent Advances and Future Directions in Endocrine Manipulation of Breast Cancer: conference summary statement.
authors.affiliation: Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA. scome@bidmc.harvard.edu
authors.forename: Steven E
authors.initials: SE
authors.lastname: Come
authors.forename: Aman U
authors.initials: AU
authors.lastname: Buzdar
authors.forename: James N
authors.initials: JN
authors.lastname: Ingle
authors.forename: Carlos L
authors.initials: CL
authors.lastname: Arteaga
authors.forename: Angela M
authors.initials: AM
authors.lastname: Brodie
authors.forename: Graham A
authors.initials: GA
authors.lastname: Colditz
authors.forename: Stephen R D
authors.initials: SR
authors.lastname: Johnston
authors.forename: Vessela N
authors.initials: VN
authors.lastname: Kristensen
authors.forename: Per E
authors.initials: PE
authors.lastname: Lønning
authors.forename: Donald P
authors.initials: DP
authors.lastname: McDonnell
authors.forename: C Kent
authors.initials: CK
authors.lastname: Osborne
authors.forename: Jose
authors.initials: J
authors.lastname: Russo
authors.forename: Richard J
authors.initials: RJ
authors.lastname: Santen
authors.forename: Douglas
authors.initials: D
authors.lastname: Yee
authors.forename: Carol S
authors.initials: CS
authors.lastname: Hart
mesh_terms: D047072:Aromatase Inhibitors / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000378:metabolism* / Q000628:therapy; D004965:Estrogen Antagonists / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D009376:Neoplasms, Hormone-Dependent / Q000628:therapy*; D020845:Selective Estrogen Receptor Modulators / Q000627:therapeutic use*; D013629:Tamoxifen / Q000627:therapeutic use
chemical_list: D047072:Aromatase Inhibitors; D004965:Estrogen Antagonists; D020845:Selective Estrogen Receptor Modulators; D013629:Tamoxifen